# Sodium Phosphates

NDC: 0517-7350
Generic name: sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous
Labeler / Manufacturer: American Regent, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20240621

FDA application: ANDA218314

## Active ingredients

- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS: 142 mg/mL
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE: 276 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0517-7350"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0517-7350
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dc0462ee-4486-418c-865f-e2a71bdb8e9e